AI-generated summary
This randomized controlled trial compared antimicrobial photodynamic therapy with topical acyclovir for herpes simplex lesions, with 12 patients in each group. The authors report no differences between the two treatments in healing time, recurrence, pain, local temperature, or quality-of-life scores over one year. Saliva viral load rose on Day 3 in the acyclovir group, but the authors state this did not translate into clinical differences.
- Who or what was studied
- Patients with herpes simplex lesions in the vesicle or ulcer phase
- Limits stated in the abstract
- The trial enrolled only 24 patients in total (12 per group), which is a small sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Randomized controlled trial, Trial registration, Primary outcome, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.